- Home
- Publications
- Publication Search
- Publication Details
Title
The expression and function of microRNA-203 in lung cancer
Authors
Keywords
miR-203, Lung cancer, Survivin, Proliferation, Apoptosis
Journal
TUMOR BIOLOGY
Volume 34, Issue 1, Pages 349-357
Publisher
Springer Nature
Online
2012-10-18
DOI
10.1007/s13277-012-0556-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Changes of microRNAs-192, 196a and 203 correlate with Barrett's esophagus diagnosis and its progression compared to normal healthy individuals
- (2012) Pavla Luzna et al. Diagnostic Pathology
- MicroRNAs as therapeutic targets and their potential applications in cancer therapy
- (2012) William CS Cho EXPERT OPINION ON THERAPEUTIC TARGETS
- MicroRNA-203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin
- (2012) Ka Bian et al. FEBS LETTERS
- MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells
- (2012) Chen Wang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis
- (2012) Alberto Izzotti et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Drosha regulates neurogenesis by controlling Neurogenin 2 expression independent of microRNAs
- (2012) Philip Knuckles et al. NATURE NEUROSCIENCE
- Immunohistochemical study of Dicer and Drosha expression in the benign and malignant lesions of gallbladder and their clinicopathological significances
- (2012) Guo-shun Shu et al. PATHOLOGY RESEARCH AND PRACTICE
- Prognostic Value of Survivin in Patients with Non-Small Cell Lung Carcinoma: A Systematic Review with Meta-Analysis
- (2012) Lou Qian Zhang et al. PLoS One
- Functional parameters of Dicer-independent microRNA biogenesis
- (2012) J.-S. Yang et al. RNA
- Survivin in Solid Tumors: Rationale for Development of Inhibitors
- (2012) David N. Church et al. Current Oncology Reports
- The Viral and Cellular MicroRNA Targetome in Lymphoblastoid Cell Lines
- (2012) Rebecca L. Skalsky et al. PLoS Pathogens
- Thermodynamic Control of Small RNA-Mediated Gene Silencing
- (2012) Kumiko Ui-Tei et al. Frontiers in Genetics
- Clarifying mammalian RISC assembly in vitro
- (2011) Grace S Tan et al. BMC MOLECULAR BIOLOGY
- miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma
- (2011) Lijuan Chen et al. CANCER LETTERS
- Contribution from cancer epidemiological studies in China
- (2011) Wei-cheng You Chinese Journal of Cancer Research
- Cancer incidence and mortality in China, 2006
- (2011) Wan-qing Chen et al. Chinese Journal of Cancer Research
- MicroRNA Alterations of Pancreatic Intraepithelial Neoplasias
- (2011) J. Yu et al. CLINICAL CANCER RESEARCH
- MicroRNAs and epigenetics
- (2011) Fumiaki Sato et al. FEBS Journal
- Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic Leukemia
- (2011) Muller Fabbri JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- MicroRNA-203 Expression as a New Prognostic Marker of Pancreatic Adenocarcinoma
- (2010) Naoki Ikenaga et al. ANNALS OF SURGICAL ONCOLOGY
- Micro-RNAs and their potential target genes in leukemia pathogenesis
- (2010) Chunjuan Dong et al. CANCER BIOLOGY & THERAPY
- Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis
- (2010) Sharanjot Saini et al. CLINICAL CANCER RESEARCH
- Lung Cancer in HIV-Positive Patients
- (2010) Suchita Pakkala et al. Journal of Thoracic Oncology
- Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression
- (2008) María J. Bueno et al. CANCER CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started